Steven Edmundowicz, MD, FASGE
Disclosures: Consulting Fee-Boston Scientific Corporation|Other: stockholder and medical advisor -Dragonfly Endoscopy|Independent Contractor (included contracted research)-AMBU|Consulting Fee-AMBU (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Fractyl|Stocks or stock options, excluding diversified mutual funds-Motus GI (Relationship has ended)|Paid consultant-Elira|Ownership-Aspero |Membership on Advisory Committees or Review Panels, Board Membership, etc.-Olympus Corporation - 12/15/2021
No Bio Available.